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ABSTRACT
Objectives

We sought to examine differences in aerobic activity (AA) and muscle
strengthening activity (MSA) by diabetes risk status (DRS) among pregnant
women in the United States.

Background

Pregnant women without complications are advised to engage in physical
activity (PA) to mitigate adverse outcomes. Differences may exist among
pregnant women of diverging diabetes status in meeting national PA
recommendations.

Methods

The sample (n=9,597) included pregnant women ages 18-44, who participated
in the 2011, 2013, 2015, and 2017 Behavioral Risk Factor Surveillance
System. Levels of DRS were: no diabetes (ND), high risk for diabetes (HRD)
due to self-reported gestational diabetes or pre-diabetes, and overt diabetes
(DM). Odds ratios (ORs) for meeting PA recommendations were obtained.
Covariates included age, race, education, household child count, alcohol
consumption, and smoking status.

Results

Findings revealed that on average, group DM had 46.5 fewer minutes of
weekly AA compared to group ND. Furthermore, a significantly lower OR
(0.39; P<0.05) for meeting both recommendations in group DM (referent ND)
was observed after adjustment.

Conclusions

We observed pregnant women with overt diabetes have a lower likelihood of
engaging in PA, while group HRD was similar in their PA engagement as
group ND. Solutions should be explored for improving PA participation in

xiii

pregnant women with diabetes so that they may also enjoy the health benefits.
Actions include increasing PA promotion by clinical providers, implementing
methods for overcoming barriers to PA, and exploring strategies to make
exercise palatable to this population.
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Chapter 1: Introduction
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BACKGROUND
Hyperglycemia refers to the presence of glucose in the blood, above the normal range (1).
In pregnancy, hormone changes lead to attenuated insulin sensitivity (2-4). As a result of
impaired glucose uptake in healthy pregnant women, excess carbohydrates are shuttled to the
placenta, providing a source of energy for fetal growth (2). Inefficiency in transporting glucose
due to insufficient or ineffective insulin action results in chronic hyperglycemia. Chronic
hyperglycemia in pregnancy may result from preexisting pre-diabetes (PD) and type 2 diabetes
mellitus (T2DM). Alternatively, previously euglycemic women may develop gestational diabetes
mellitus (GDM) due to inability to compensate for the rising insulin resistance (5). Physical
activity (PA) has been shown to reduce the risk of adverse outcomes in pregnant women with
and without hyperglycemia (6). Despite the abundance of evidence on the benefits of PA in
pregnancy (7), several factors (8-12) contribute to the dismal amount of activity among pregnant
women (13).
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GESTATIONAL DIABETES MELLITUS
Gestational diabetes, or hyperglycemia first recognized during pregnancy, typically
resolves at, or shortly after, delivery (14). According to a study based on data from the 20072014 National Health and Nutrition Examination Survey (NHANES), the estimated prevalence
of GDM in the U.S. is 7.6% (15). However, due to variable diagnostic criteria and screening
methods throughout the years from various governing bodies (Table 1), incongruent prevalence
estimates for GDM exist (16,17). Screening and diagnostic tests are typically given at 24-28
weeks gestation (18,19). The most common screening method in the U.S. is the 50g, 1-Hour (H)
oral glucose tolerance test (OGTT), endorsed by the American Diabetes Association (ADA) and
the American College of Obstetricians and Gynecologists (ACOG) (20, 21) (Table 1). Diagnostic
methods may be one-step or two-step with the 50g 1-H OGTT included as an initial screen. The
one-step diagnostic method endorsed by the The International Association of Diabetes
Pregnancy Study Groups (IADPSG) and the ADA are the fasting plasma glucose (PG), and the
1-H and 2-H OGTT following a 75g glucose load (18). Diagnostic criteria for GDM include a
fasting PG between 92 and 125 mg/dl, a 1-H PG ≥180 mg/dl and a 2-H PG between 153 and 199
mg/dl following the OGTT (18,19). Additionally, the two-step approach recommended by the
ACOG utilizes the initial 50g 1-H OGTT screening prior to the 3-H OGTT following a 100g
glucose load (21) (Table 1. Furthermore, diagnostic demarcation points for fasting PG vary
depending on the test given.
Women with GDM are at a seven-fold increased risk for developing T2DM (22) and a
50% increased risk for developing cardiovascular disease (CVD) (23). Furthermore, one-third of
women with GDM develop postpartum depression (24). Other sequelae include increased risk
for perinatal mortality, fetal macrosomia, neonatal hypoglycemia, caesarean section, and
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postpartum depression (25). Moreover, their offspring are at a higher risk for glucose intolerance,
T2DM, and obesity.
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Table 1. Screening and diagnostic recommendations for GDM
Screen

IADPSG
(19)

None

Diagnosis

2 h 75 g OGTT
Diagnosis if 1 or more glucose ≥:
Fasting 5.1 mmol/L (92 mg/dL), 1 h
10.0 mmol/L (180 mg/dL), 2 h 8.5 mmol/L
(153 mg/dL)

3 h 100 g OGTT
Diagnosis if 2 or more ≥:
Fasting 5.3 mmol/L (95 mg/dL), 1 h
50 g glucose challenge test
10.0 mmol/L (180 mg/dL), 2 h 8.6 mmol/L
Abnormal: can choose from 7.2 mmol/L
ACOG (21)
(155 mg/dL), 3 h 7.8 mmol/L (140 mg/dL)
(130 mg/dL), 7.4 mmol/L (133 mg/dL),
or
or 7.8 mmol/L (140 mg/dL)
Fasting 5.8 mmol/L (105 mg/dL), 1 h
10.6 mmol/L (190 mg/dL), 2 h 9.2 mmol/L
(165 mg/dL), 3 h 8.0 mmol/L (144 mg/dL)
ADA (20)

One-step: none
or
Two-step: see ACOG

Preferred approach: 50 g
Glucose challenge test
Diabetes Abnormal if ≥ 7.8 mmol/L (140 mg/dL)
Canada (26) Diagnostic if ≥ 11.1 mmol/L
(200 mg/dL)
Alternative approach: None
WHO (27)

None

One-step: see IADPSG
or
Two-step: see ACOG
Preferred approach: 2 h 75 g OGTT
Diagnosis if 1 or more ≥: Fasting
5.3 mmol/L (95 mg/dL), 1 h 10.6 mmol/L
(190 mg/dL), 2 h 9.0 mmol/L (162 mg/dL)
Alternative approach: See IADPSG
—a

a
As of March 8, 2018, this statement has been added: “WHO currently does not have a
recommendation on whether or how to screen for GDM, and screening strategies for
GDM are considered a priority area for research, particularly in LMICs.”
Note. Adapted from “Chapter 22- Gestational Diabetes and Type 2 Diabetes During Pregnancy”
by Mukerji, Bacon & Feig. Maternal-Fetal and Neonatal Endocrinology. 2020:371-388.
Copyright © 2020 Elsevier Inc. All rights reserved.
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PREDIABETES
An estimated 36% of women in the U.S. have PD (14). The screening methods outside of
pregnancy are the same as with T2DM: fasting PG, 2-H OGTT with a 75g glucose load, and
glycosylated hemoglobin (A1C) (18). Demarcation points for PD diagnosis are fasting PG, 2-H
PG, and A1C ranging from 100-125 mg/dl, 140-199 mg/dl, and 5.7-6.45%, respectively.
Although PD is not as detrimental as T2DM, 5-10% of patients with PD progress to T2DM
annually (28). Though similar recommendations are made for T2DM and GDM, particular
emphasis on weight loss of 5-10% of body weight and 30 minutes a day of moderate intensity
aerobic activity (AA) is recommended as a first line treatment for patients with PD for
prevention of progression of disease severity (28).

TYPE 2 DIABETES MELLITUS
Nearly 14% of the total population of U.S. women have T2DM, with the prevalence
increasing with age (14). Approximately 2.9% of women of a reproductive age have been
diagnosed with diabetes (29). A 2005-2006 report in Ontario, estimated 4.3/1000 cases of T2DM
in pregnancy (30). Risks associated with T2DM are diverse and can have life-altering
implications such as augmented risk for CVDs (31). Other serious consequences include
blindness, kidney failure, lower limb amputations, cardiovascular events, and complications in
pregnancy (1,27). A patient must have two abnormal test results from the same test to confirm
T2DM diagnosis. Demarcation points for T2DM diagnosis are as follows: fasting PG ≥126
mg/dl, 2-H PG ≥200 mg/dl, and A1C ≥6.5% (18).
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PHYSICAL ACTIVITY IN PREGNANCY
Pregnancy is a unique time in a woman’s life where her daily activities impact both
herself and her unborn child. Therefore, PA recommendations are made with both maternal and
neonatal health in mind. The 2020 ACOG recommend that all pregnant women without
complications stay active and engage in both aerobic and strength conditioning exercises (7). In
the absence of further evidence of PA dosage, ACOG supports the 2018 guidelines for PA in
pregnancy set out by the U.S. Department of Health and Human Services (DHHS) (32).
According to the guidelines, pregnant women should engage in at least 150 minutes of moderate
intensity aerobic activity (AA) throughout the week (32). Moderate intensity is defined as any
activity that is 3-4 METS, or the equivalent to brisk walking (33). Healthy pregnant women who
regularly engage in vigorous AA can continue but should communicate with their healthcare
provider on how to safely do so as the pregnancy progresses (2). Current U.S. recommendations
do not include muscle strengthening activity (MSA) recommendations for pregnant women.
However, the 2019 Canadian Guidelines for Physical Activity throughout Pregnancy (3) do
generally encourage resistance training.
In addition to PA recommendations for overall wellness, specific recommendations are
also made for management of GDM and T2DM in pregnancy (34) In line with the 2018 DHHS
guidelines for PA in pregnancy, the Fifth International Workshop-Conference on Gestational
Diabetes recommended moderate intensity PA for 30 minutes a day on most days of the week for
management of GDM (35). Similarly, the ADA recommends women with pre-existing diabetes
of any kind to engage in 20-30 minutes of moderate intensity PA on most days of the week, prior
to and during pregnancy (36).
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The ACOG has previously listed absolute and relative contraindications to exercise in
pregnancy (37). However, absolute contraindications are uncommon. Relative contraindications,
such as poorly managed type 1 diabetes, may be addressed by consulting with a specialist,
appropriate diet, and individualized exercise programming (7). In addition, pregnant women are
advised against participating in contact sports, high fall risk sports, scuba diving, sky diving, and
exercising in hyperthermal environments such as in hot yoga. Due to lack of evidence, bedrest is
no longer recommended in women at risk for preterm birth or preeclampsia (38,39). Bedrest
increases the chances of venous thromboembolism, bone demineralization, and deconditioning
(38).
Several health benefits may occur in physically active pregnant women. In a randomized
control trial of 62 pregnant women, the aerobic PA group (n=31) improved both aerobic fitness
and muscular strength, when compared to sedentary controls (P<0.05). Furthermore, there were
fewer caesarean sections and faster postpartum recovery in the exercise group (p<0.05) (40). The
inverse relationship between PA and caesarean deliveries has been extensively published (4143). Moreover, PA has been found to be inversely associated with preeclampsia (44). A metaanalysis of 40 observational studies reported a 30% reduction in GDM risk for any general
inclusion of PA (45). Physical activity improves blood sugar levels by restoring insulin
sensitivity and minimizing glucose intolerance (46Structured exercise programs may reduce the
risk of GDM by 30% (47). In a 2017 randomized controlled trial of 300 overweight or obese
pregnant women, 30 minutes of cycling three times per week, beginning in the first trimester
until 37 weeks gestation, significantly reduced incidence of GDM (22.0% vs 40.6% in the
control group; P < 0.001).
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Although less researched, some evidence exists for the benefits of MSA in pregnancy. In
a clinical trial of 26 pregnant women, low to moderate intensity strength training two days per
week for 12 weeks transiently improved mental and physical energy levels and reduced fatigue,
independent of AA (48). A study of 139 pregnant women revealed that feelings of energy were
increased and fatigue symptoms were reduced among 56 pregnant women who completed 50
minutes of unspecified strengthening and stretching exercises of an unspecified intensity that
involved exercise-balls, Pilates, and yoga type movements (49).

ESTIMATED PREVALENCE OF PHYSICAL ACTIVITY IN PREGNANCY
Based on 2010-2015 National Health Interview Survey data, only one-third of adult
women meet the recommended 150 minutes moderate intensity AA (or vigorous equivalent) and
two days of MSA per week (50). Moreover, a 2007-2014 NHANES study reported only 23% of
pregnant women in the U.S. met the recommended 150 minutes of moderate intensity AA and
only 12% did so by exercising throughout most of the week (51). Accelerometry data from 20032006 NHANES reported roughly one-third of all women did not engage in any PA during
pregnancy (52). Thus, clinicians are likely to more often encounter women who are inactive or
insufficiently active. Additional factors associated with meeting PA recommendations are
education level, age, non-Hispanic white race, being unmarried, not smoking, higher income, and
general health status (53).
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BARRIERS TO PHYSICAL ACTIVITY IN PREGNANCY
Although the benefits of exercise in pregnancy have been widely published, there are
several factors that may negatively impact exercise behavior in pregnant women.
In a systematic review examining correlates of PA in pregnancy, mental health, prior PA,
self-efficacy, and intention to be physically active have among the strongest effect sizes
contributing to PA engagement (54). A 2017 review of qualitative and quantitative evidence
revealed that lack of time due to work, tiredness, pregnancy-related symptoms, and lack of social
support were among the most prominent barriers to PA participation. Furthermore, despite the
ACOG recommendations on the benefits of exercise, there is a prevailing fear related to risk of
miscarriage, growth restriction, pre-term birth, fatigue, and harm to the fetus, among patients and
clinicians (55).
Exercise programs led by a trained professional (i.e., exercise physiologist) may mitigate
some of these fears and bypass barriers related to lack of knowledge (56) and motivation (55).
One study examined the efficacy of at home versus face-to-face exercise programming with a
trainer for women with GDM (57). The intervention took place from about 20 weeks to 32 weeks
of gestation. At the 32-week follow up, women receiving the face-to-face intervention had a
higher number of pedometer steps per day, significantly higher exercise minutes (p<0.05), and
positive motivational determinants (attitude, subjective norm, perceived control, intention).
Moreover, postprandial blood glucose after 36 weeks of gestation was lower in the face-to face
group than the at home group.
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ABBREVIATED LITURATURE REVIEW
Normal physiological changes leading to insulin resistance in a healthy pregnancy may
be exacerbated in women with overt diabetes and undetected endothelial dysfunction, leading to
maternal hyperglycemia (2). Numerous studies demonstrate the role of PA before and during
pregnancy in reducing the risk of maternal hyperglycemia (37,58-60). Furthermore, pregnant
women who have already been diagnosed with hyperglycemia can improve their glycemic
control through PA (46,61,62). Risk factors associated with maternal hyperglycemia such as
older age (25), minority ethnicity, elevated BMI, having children, and education level, have also
been tied to PA participation (23). Exercise interventions have explored various methods of
reaching this population to promote PA by tackling social, cognitive, and emotional barriers (6366).

PURPOSE AND STUDY AIM
To our knowledge, this is the first study to examine PA in GDM and PD together as one
high-risk for diabetes group. This study adds to the evidence demonstrating differences in PA
engagement among pregnant women at high-risk for diabetes, overt diabetes, and no diabetes.
Therefore, we aim to answer three questions:
1.Is there an association between diabetes risk status (DRS) and meeting the 2008
DHHS recommendation for PA in pregnancy?
2.Is there an association between DRS and engaging in the DHHS adult recommendation
of at least two days of MSA per week in pregnant women?
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3.What are the major characteristics that are associated with meeting the pregnancy PA
recommendations and two days of MSA?

PROJECT DESCRIPTION
This secondary analysis used data from the Behavioral Risk Factor Surveillance System
(BRFSS) in the interview years, 2011, 2013, 2015, and 2017. Only the odds years between 2011
and 2017 were used due to more in-depth PA questions. The population sample was limited to
pregnant women between the ages of 18-44 who had complete data on all the variables of
interest. Further exclusion of probable type 1 diabetes brought the population sample size to
9,597 participants. Women with self-reported GDM and PD were identified as the high-risk for
diabetes (HRD) group. Women with self-reported diabetes were in the diabetes mellitus (DM)
group. Women who reported no diabetes were in the no-diabetes (ND) group. Aerobic activity
and MSA were dichotomized into ‘meets,’ and ‘does not meet,’ the 2008 DHHS PA guidelines.
Note that the 2008 DHHS recommendations are used as the standard of measurement
instead of the more recent 2018 DHHS recommendations. This is due to the survey designs of
the 2011, 2013, 2015, and 2017 BRFSS, where duration of a single bout of reported PA that is
under 10 minutes is not counted. New guidelines allow for a minimum of 2-minute bouts.
Therefore, an accurate measurement of meeting the 2018 guidelines cannot be ascertained from
the present data. Furthermore, all data utilized in this project was collected prior to the release of
the 2018 PA guidelines.
Other limitations to the study are as follows:
1. Due to the cross-sectional study design, we cannot infer causality.
2. All data was self-reported; therefore, all data is subject to recall bias.
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3. There are no objective measures.
4. Contraindications to exercise may exist but we are unable to obtain this information from
the survey.
5. We cannot control for adiposity due to lack of information on pre-pregnancy BMI.
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The chronic hyperglycemia seen in gestational diabetes mellitus (GDM), prediabetes
(PD, and type 2 diabetes mellitus (T2DM) is a result of insulin resistance (1) and can lead to
adverse health outcomes during and after pregnancy (2-8). In 2017, the estimated worldwide
prevalence of combined GDM and pre-existing diabetes in pregnancy was 16.2% (9). Symptoms
of hyperglycemia include polyuria, polydipsia, polyphagia, and increased sensitivity to certain
infections (10).
Pregnancy is an opportunity in a woman’s life for establishment of healthy lifestyle
practices that carry maternal and fetal benefits (11). The American College of Obstetricians and
Gynecologists (ACOG) recommend physical activity (PA), as it is linked to prevention of GDM,
other cardiometabolic diseases and pregnancy complications (11,12). The factors leading to PA
engagement are complex and may be related to factors contributing to diabetes.
This chapter includes a discussion of the hormonal and immunological changes in
pregnancy leading to insulin resistance, a history of hyperglycemia in pregnancy, definitions and
diagnoses of T2DM, GDM, and PD, an overview of adverse outcomes due to hyperglycemia,
risk factors associated with diabetes, evidence of PA for improved glycemic control and GDM
prevention in pregnancy, potential barriers to engaging in PA, and exercise interventions.
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BIOLOGICAL MECHANISMS OF HEALTHY AND HYPERGLYCEMIC
PREGNANCIES
During the second half of pregnancy, skeletal muscle attenuates the glucose disposing
actions of insulin by about 50% to accommodate the energy needs of the fetus (13). Insulin
resistance arises from a combination of hormonal changes and is part of the natural physiology
associated with a healthy pregnancy. The pathological outcomes of hyperglycemia in pregnancy
arise from the coexisting issues related to insulin resistance and endothelial dysfunction (14-17).
This section will cover key issues in the progression of physiological insulin resistance and
identify distinguishing characteristics of pathological insulin resistance in pregnancy.
Reduced insulin signaling during pregnancy is partially due to attenuated adiponectin
action. Adiponectin, a protein made in adipocytes, placenta, and skeletal muscle (18,19), acts as
an insulin sensitizer by activation of peroxisome proliferator-activated receptor and 5’ adenosine
monophosphate-activated protein kinase in both the skeletal muscle and liver, inducing glucose
transporter type-4 (GLUT4) translocation and fatty acid β-oxidation (20). Adiponectin levels
normally decline slightly in late pregnancy (21).
Leptin, also made by adipose tissue (22), placenta (23), and skeletal muscle (24), possess
insulin sensitizing actions (22). Secretions of leptin peak during the late 2nd and early 3rd
trimester, leading to greater fat accumulation, satiety, and fatty acid oxidation in skeletal muscle
(25). Leptin increases glucose uptake by stimulation of sympathetic nerves and B2 adrenergic
receptors in myocytes (26). Over the course of pregnancy, the downregulation of the OB-Rb
receptor induces leptin resistance, decreasing energy intake into cells of the mother (27).
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The increase in sex hormones (28), progesterone (Pg) and estrogen may also play a role
in the desensitization of insulin receptors. Higher concentrations of Pg may reduce expression of
insulin receptor substrate (IRS)-1 and inhibit insulin-induced GLUT4 translocation and glucose
uptake into skeletal muscle (29). Animal studies on pregnant rats have demonstrated that
estradiol (E2) does the opposite- increasing receptor binding as well as expression and
membrane translocation of GLUT4 in adipocytes (30). During late pregnancy, higher levels of
E2 repress GLUT4 expression in skeletal muscle (31) and a reduction in insulin binding is
induced by Pg, cortisol, prolactin, and human placental lactogen (hPL) (32).
The prolactin family, hPL and human placental growth hormone (hPGH) are produced in
early pregnancy and gradually increase during gestation, contributing to the progression of
insulin desensitization in skeletal muscle (13,33). Early in pregnancy, hPL stimulates the growth
of pancreatic islets, increasing insulin secretion (34). In mid to late pregnancy, hPL stimulates
3H-thymidine incorporation, insulin gene transcription and production, and glucose-dependent
insulin secretion in pancreatic islet cells which may lead to postprandial hyperglycemia and
hyperinsulinemia (35). Insulin resistance could also be induced by hPL binding to the growth
hormone receptor (32). Insulin signaling may be further limited by hPGH action (13).
Tumor necrosis factor- alpha (TNF-α), a cytokine produced by white blood cells,
fibroblasts, adipocytes, and the placenta, may impair insulin signaling by acting as a
serine/threonine kinase of insulin receptor substrate (IRS) – 1 (35). Additionally, in mid to late
pregnancy, TNF-α suppresses the transcription of adiponectin (13).
Abnormal hormone responses in pregnancy present in women with GDM and T2DM
(14,15,17,36). Women with T2DM exhibit impaired vascular reactivity and an attenuated
response to estrogen stimulation (14,15,36); whereas, estrogen contributes to enhanced insulin
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resistance in women with GDM (17). Additionally, lower levels of adiponectin in pregnancy
correlate to diagnosis of GDM (37).
The differentiation between insulin resistance in normal and hyperglycemic pregnancies
is due to divergence in specific mechanisms leading to glucose transport. A BMI and agematched study compared glucose transport activity and expression and phosphorylation of the
insulin receptor and IRS-1 in women with GDM (n=7), pregnant women without GDM (n=11)
and non-pregnant women (n=11) (38). Biopsies from the rectus abdominus were obtained from
the three groups. Findings revealed a 32% lower rate of maximal insulin-stimulated 2deoxyglucose transport in the non-GDM pregnant group when compared to the non-pregnant
control. Moreover, there was an additional 54% lower rate in the GDM group when compared to
the non-GDM pregnant group (P<0.05). The maximal effect of insulin on tyrosine
phosphorylation of the insulin receptor was 37% lower in the GDM group versus the non-GDM
pregnant group (P<0.05). There was a 23% (P<0.05) and 44% (P=0.002) reduction in the IRS-1
protein levels in muscle from non-GDM and GDM pregnant women, respectively. Although
based on a small number of women, the findings of this study indicate that insulin resistance to
glucose transport during pregnancy is associated with a decrease in IRS-1 tyrosine
phosphorylation, mainly due to decreased expression of IRS-1 protein. In pregnant women with
GDM, a decrease in tyrosine phosphorylation of the insulin receptor beta-subunit is associated
with further decreases in glucose transport activity (38).
Higher concentrations of inflammatory biomarkers have also been associated with
hyperglycemic conditions. Garcia et al. (39) discusses the relationship between diabetes and
inflammation. Inflammation may coexist or amplify diabetes by toll-like receptor pathways that
detect liposaccharides (LPS). Saturated fatty acids stimulate production of TNF-α and interleukin
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(IL-6). Obesity-induced diabetes propagates in part by high LPS levels that stimulate certain
inflammatory response proteins in endothelial cells, which is also associated with insulin
resistance. High stress levels (i.e., from poor lifestyle choices) can increase blood pressure
through the sympathetic nervous system, thereby promoting inflammatory effects on the
endothelium. This can promote interleukin synthesis, which is a potential biomarker of diabetes
and PD. Abnormally high neutrophil-platelet volumes exist in those with PD and diabetes and,
therefore, reliably marks the presence of inflammation in these patients. Likewise, neutrophil
gelatinase-associated lipocalin, another inflammatory marker, is seen in higher serum
concentrations in women with GDM. IL-6 and C - reactive protein (CRP) are both
verifiable inflammatory biomarkers of diabetes in women. TNF-α, IL-6, CRP, vascular adhesion
molecule- 1, intercellular adhesion molecule, E- and P-selectins, von Willebrand Factor,
plasminogen activator inhibitor 1, fibrinogen and adiponectin, may also be associated with the
development of T2DM (39).
In summary, insulin resistance in pregnancy arises from myriad biochemical mediators.
Increased insulin resistance may be exacerbated by underlying, endothelial dysfunction. This
increase in insulin resistance leads to compromised glucose transport, leading to hyperglycemia.

HISTORY, DEFINITIONS, AND DIAGNOSIS OF HYPERGLYCEMIA IN
PREGNANCY
The conglomeration of increased GDM (40), PD, and T2DM (41) in women of a
childbearing age has led to the rising prevalence of hyperglycemia requiring clinical
management in pregnancy (9). In 2013, a global estimate of 21.4 million women had
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hyperglycemia in pregnancy (42). Environmental factors and universal screening for all
asymptomatic pregnant women are largely responsible for this uptrend (43, 44)
Classification of hyperglycemia has evolved. In 2010, the International Association of
Diabetes and Pregnancy Study Groups (IADPSG) created three categories for hyperglycemia in
pregnancy: pre-gestational diabetes (PGDM), overt diabetes first recognized in pregnancy (DIP),
and GDM (45). Three years later, the World Health Organization (WHO) followed suite,
implementing this categorization as well (46). Pre-gestational diabetes is defined as established
diagnosis of hyperglycemia prior to pregnancy. Gestational Diabetes Mellitus (GDM) is
unregulated blood glucose that initiates during pregnancy and terminates after delivery (47).
Prior to the First International Workshop on GDM in 1980, the American Diabetes
Association (ADA) recommended glucose screening in pregnant women at a higher risk for
diabetes. As universal screening became more widely adopted, prevalence rates of GDM grew.
Hyperglycemia and Adverse Pregnancy Outcomes Study (HAPO), published in 2008, reinforced
the negative implications of hyperglycemia below levels of overt diabetes in pregnancy.
Specifically, they highlighted the strong, continuous association of maternal glucose levels with
increased birth weight and increased cord-blood serum C-peptide levels.
Prediabetes, also called borderline diabetes, in pregnancy has not been well researched, in
part because PD often goes undiagnosed until pregnancy, when it is then classified as GDM (48).
The oral glucose tolerance test (OGTT) is the most widely accepted method of assessing
hyperglycemia in pregnant women without PGDM. According to the 2013 WHO
Recommendations, a diagnosis of GDM is valid if the fasting plasma glucose (FPG) is 5.16.9 millimoles per liter (mmol/L) (92-125 mg/dl, the 1-hour (h) PG is ≥ 10.0 mmol/L (180
mg/dl) following a 75 g oral glucose load, or the 2-h PG is 8.5-11.0 mmol/L (153 -199 mg/dl)
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following a 75g oral glucose load. Plasma glucose values above the upper demarcation points are
grounds for diagnosing DIP (46).
Diagnostic criteria for women with PD and T2DM include the fasting PG and OGTT
along with a glycohemoglobin (A1C) test. The A1C test is not recommended for diagnosing
diabetes in pregnancy due to equivocal findings and increases in red blood cell turnover in
pregnancy (49). Pre-gestational diabetes is confirmed by a FPG of ≥ 126 mg/dl, an OGTT two-h
PG ≥ 200 mg/dl after a 75g oral glucose load, or a A1C concentration of ≥6.5%. Diagnosis for
PD in non-pregnant women is a fasting PG between 100 and 125 mg/dl, an OGTT 2-h reading
between 140 and 199 mg/dl or an A1C from 5.7 to 6.4% (50).

RISK FACTORS
There are several factors associated with maternal hyperglycemia; being above the age of
25, an abnormal body weight before pregnancy, being a member of an ethnic group
(e.g., Filipino and Hispanic) with a high prevalence of GDM, immediate family members with a
history of diabetes, a history of abnormal glucose tolerance, or a history of poor obstetric
outcome (4). African American and Hispanic women are particularly susceptible to diabetes
compared to other racial minorities (51). Education level has been shown to be a predictor of
T2DM and potential predictor of GDM (52). Alcohol consumption in moderation has been
shown to reduce the likelihood of diabetes (53). However, excessive consumption may have
deleterious effects on glycemic control. Smoking status is also associated with poor glycemic
control (54). A consistent, positive dose response exists between BMI and outcomes of GDM
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(55). Overweight women are twice as likely, obese four times more likely, and severely obese
eight times more likely to acquire GDM.
Endothelial dysfunction, a hallmark of PD, is strongly associated with T2DM (56). The
metabolic pathways leading to T2DM are closely associated with cardiovascular diseases,
hypertension, and lipoprotein metabolism. Type 2 diabetes bears a robust association with
environmental risk factors and accounts for 90-95% of those with diabetes. This type of diabetes
relates closer to obesity/adiposity more than with type 1 diabetes (50).

ADVERSE OUTCOMES
Gestational diabetes mellitus patients face more than a seven-fold increased risk in
developing T2DM (3,57). The first five years after delivery has been identified as a critical
window in which this risk is greatest (58). Indeed, even without GDM, five to ten percent of
patients with PD progress to T2DM annually (7).
Potential permanent consequences to diabetes includes loss of vision, renal failure, and
peripheral neuropathy, amputations, Charcot joints (neuropathic joint), and foot ulcers (50). The
estimated economic burden of diabetes in 2017 was $327 billion (59). The average female with
diabetes incurs about $9110 per year in medical costs for diabetes alone (59). The projected
increase in diabetes prevalence in the US before 2030 is 1.0 million per year (60). By this
estimate, by 2060 19.6% of all women in the US will have diabetes compared with the 9%
prevalence in 2014 (a potential 118% increase). The interconnection of insulin resistance,
endothelial dysfunction and atherosclerosis reinforces the relationship between T2DM
and vascular diseases such as coronary artery disease (56).
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After the first diagnosis of GDM, the risk of developing another metabolic condition
escalates (61). When a nulliparous woman receives the diagnosis, she has a 41% higher risk of
developing GDM again during a subsequent pregnancy. A study compared glucose tolerance,
insulin levels, biochemical parameters, and brachial vasodilatory responses between 16 obese, 17
non-obese women previously diagnosed with GDM, and 19 healthy non-obese women
(62). Results revealed a reduced flow-mediated dilation in the brachial arteries of women with
normal glucose tolerance but a history of GDM, signifying vascular impairment. Non-obese
women with a history of GDM also had high uric acid levels, a marker of insulin resistance,
suggesting an association between hyperglycemia in pregnancy and post gravid metabolic
dysfunction independent of adiposity.
The HAPO study brought to light pregnancy-related sequelae that arise from
hyperglycemia below established PD and GDM levels (63). Such negative implications included
preeclampsia, hyperbilirubinemia, intensive neonatal care, shoulder dystocia/birth injury,
premature delivery before 37 weeks, high cord-blood serum C peptide, clinical neonatal
hypoglycemia, primary cesarean section, and birth weight >90th percentile. A prospective study
in south India found that mothers with GDM have a mean body weight of 9.9 kg more than
controls (2). Their BMI was 28.8 vs 25 in the control group. Neonatal complications associated
with the GDM pregnancies included macrosomia, premature pregnancy, sacral agenesis,
ventricular septum tumor syndrome, hypoglycemia, respiratory distress, and death (2). Obesity
further complicates women with maternal hyperglycemia, heightening their chances of
developing preeclampsia and metabolic syndrome. Women with maternal hyperglycemia and
higher BMIs also give birth to more babies with macrosomia, hypoglycemia, and fetal diabetes
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(6). In addition to these consequences, T2DM in pregnancy can amplify the severity of these
outcomes and contributes to higher likelihood of congenital abnormalities and stillbirth (64).
Children exposed to hyperglycemia in utero face additional dangers. These children are at
a higher risk for coronary artery disease and atherosclerosis (65,66) as well as glucose
intolerance, T2DM, and obesity (4). According to a cross-sectional study using the California
Cancer Registry from 1988 to 2013, several childhood cancers such as acute lymphoblastic
leukemia and Wilm's tumor were associated with pre-pregnancy diabetes as well as maternal
overweight conditions (66).

PHYSICAL ACTIVITY RECOMMENDATIONS, BENEFITS, BARRIERS, AND
INTERVENTIONS
RECOMMENDATIONS
Table 1 summarizes considerations relevant to pregnancy for implementing an exercise
prescription. Specific recommendations such as moderate intensity and thermoneutral
environment are made to prevent fetal stressors (12).
Specific clinical recommendations have been made for women with hyperglycemia (67).
Preconception counseling and lifestyle changes are recommended in women with pre-existing
T2DM and GDM, respectively. Both recommendations include PA promotion during pregnancy.
First line treatment in PD for prevention of overt diabetes includes weight loss of 5-10% of body
weight and 30 minutes a day of moderate intensity physical activity (PA) (7).
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Table 1. Characteristics of a Safe and Effective Exercise Regimen in Pregnancy
First Trimester, More than 12 Weeks of gestation
Duration of session

30-60 minutes

Times per week

At least 3-4 (up to daily)

Intensity of exercise

Less than 60-80% of age-predicted maximum maternal heart rate*

Environment

Thermoneutral or controlled conditions (air conditioning; avoiding
prolonged exposure to heat)
Moderate intensity (12-14 on Borg scale)

Self-reported intensity of
exercise (Borg scaleᵃ)
Supervision of exercise
When to end

Preferred, if available
Until delivery (as tolerated)

*Usually not exceeding 140 beats per minute; ᵃ Borg scale is a 15-category scale (from 6-20) to

measure the level of perceived exertion: light exercise is approximately 6-11; 13 is somewhat hard; 15
is hard; 19 is extremely hard
Note: Adapted from “Exercise is pregnancy! “ by Berghella V, Saccone G. Am J Obset Gynecol.
216:335-7, 2017. Copyright

BENEFITS OF EXERCISE AND PHYSICAL ACTIVITY
Exercise plays a crucial role in prevention and treatment of hyperglycemia in pregnancy
through counteraction of metabolic pathways associated with increased glucose uptake,
hypertension, chronic systemic inflammation, dyslipidemia, and oxidative stress (68).
A multitude of observational studies have examined the positive impact PA plays in
treatment and prevention of hyperglycemia in pregnancy. A meta-analysis of 40 observational
studies reported a 30% reduction in GDM risk for any general inclusion of PA (69). A
prospective cohort study assessed pre and current pregnancy PA and incidence of GDM in 909
women in Tacoma, Washington (70).When compared to inactive women, they observed a 56%
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risk reduction in GDM incidence (RR 0.44; 95% CI 0.21-0.91) for any participation of PA in the
year before pregnancy. Additionally, a 76% risk reduction in GDM incidence (RR 0.24; 95% CI
0.10-0.64) was observed for women engaging in at least 4.2 hours/wk of pregravid PA. Physical
activity both before and during pregnancy resulted in a 69% reduction in the GDM incidence
risk (RR 0.31; 95%CI 0.12, 0.79) when compared to inactive women. Previously inactive women
who decide to participate in PA during pregnancy can reduce their chances of developing GDM.
In a study using data from the 1988 National Maternal and Infant Health Survey (71), 4,813
women who reported being physically inactive before pregnancy, with singleton births and no
previous diabetes diagnosis were examined. Findings revealed 57% lower adjusted odds (OR
0.43, 95% CI 0.20-0.93) of developing GDM in women who became physically active when
compared to those who remained inactive in pregnancy.
Various randomized controlled trials (RCTs) with different modes of exercise have also
shown improvements in glycemic measures. One RCT including 342 pregnant women from
Spain examined the effectiveness of exercise beginning in early pregnancy (~12 weeks) on GDM
incidence. The intervention group (n=101) exercised for 60 minutes on land and 50 minutes in
water 3x/wk. At the end of the trial, there was a lower prevalence of GDM in the exercise group
(n=1) than in the usual care group (n=8) (P=0.009) (72). Another RCT aimed to find the effect of
exercise on PG levels in 41 parous women (20-33 weeks' gestation) with persistent fasting
hyperglycemia between 105 and 140 mg/dl (73). Subjects were either treated with insulin
(control) or exercised on a cycle ergometer at moderate intensity 3x/wk. As a result of the
exercise intervention, pregnant women had regulated blood glucose levels in normal range for
the rest of their pregnancy and did not require insulin . Furthermore, one study took (n=19)
women with gestational diabetes to perform upper arm ergometry 3x/wk, 20 min each session,
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50% VO2max (74). Findings demonstrated a normalization in glycemic control after 4 weeks, as
opposed to diet alone.
Leisure-time physical activities (LTPA) have been shown to lower the chances of
developing diabetes and PD (75,76). One prospective study of 21,630 men and women in
Finland assessed the relationship of occupational, commuting, and LTPA with the incidence of
T2DM (75). Measurement of the three types of PA were ascertained through surveys
administered in 1982, 1987, and 1992. The National Hospital Discharge Register and the
National Social Insurance Institution’s Register were linked to the study participants to identify
T2DM incidents. Notably, women who had high occupational PA levels had the highest mean
BMI, systolic blood pressure, and obesity prevalence. There was no significant association
between occupational PA and T2DM in women. Commuting PA exhibited a significant inverse
relationship with T2DM in women.
Strength training in women with hyperglycemia may prove especially beneficial because
glucose disposal occurs primarily in the skeletal muscle cells (13). Morais, et al. compared
cardiovascular and strength interventions in older adults with and without diabetes by measuring
the circulating microRNA (c-miR) concentrations of c-miR-126, c-miR-146a, and c-miR-155,
which are associated with lower PG levels (77). Results indicate an increase in c-miR in PG and
particularly c-miR-146a levels in those who engage in strength training. Both T2DM and control
groups increased plasma levels of c-miR with a greater increase in the T2DM group. The
increase c-miR-146a plasma levels have a reported negative association with blood glucose
levels. Interestingly, those in a subgroup performing only cardiovascular interventional training
did not have any change in c-miR-146a regardless of diabetes status . This and other studies
illuminate the role of resistance training on the prevention of T2DM and its effect on
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inflammation. A 2015 study utilizing data from the 1999-2004 National Health and Nutrition
Examination Survey found that women who engaged in muscle strengthening activity (MSA)
had significantly lower levels of CRP (78).

BARRIERS
Despite clinical recommendations, evidence suggests low adherence to adequate PA
requirements in pregnant women and non-pregnant women with a history of GDM (hGDM) and
current diabetes. One study using 2001-2003 BRFSS data reported that women with hGDM are
not more likely to adopt healthy lifestyle behaviors than their non-GDM counterparts, suggesting
that awareness of disease does not positively influence change in behavior (79). Another study
using 2003 BRFSS data observed approximately 57.4% of the hGDM group and 70.9% of the
current diabetes group did not meet the PA recommendations. Moreover, women reporting to
currently have diabetes or hGDM were significantly more likely to engage in no LTPA (OR 1.4
and 1.4 respectively; P<0.05) and to fail to meet the national PA recommendations (OR 1.4 and
1.2 respectively; P<0.05) (80). Smith et al. studied the prevalence of meeting PA guidelines
using METs to assign sufficient PA, low PA, or sedentary behavior (81). A survey was given to
226 women who had previously been diagnosed with GDM. Of the 226 women, 26.1% were
sedentary, 39.4% had low PA levels, and 33.2% were sufficiently active. Most of the women
with enough activity were English speaking. An estimated 48.9% of participants reported not
knowing what PA level would be enough for prevention of diabetes. Swan et al. indicated that
58% of women were in a pre-action stage for strenuous activity and, therefore,
inactive (82,83). After a comprehensive review of eighteen studies, Kaiser
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and Razurel concluded that compliance to the PA recommendations was inadequate in this
population (84).
A unique combination of factors contributes to exercise decisions in pregnancy. Among
them are lack of knowledge on sport and exercise, inconvenience (85), other health problems,
low self-efficacy (86,87), lack of time due to work and childrearing (88), tiredness, pregnancyrelated symptoms, lack of social support, and uncertainty on the risk of adverse pregnancy
outcomes (89). In an analysis of determinants of health behaviors among women with GDM
(90), the “attitudes towards weight loss” scale was independent of PA participation. Emotional
encouragement and self-efficacy were significant in determining PA levels.
Socioeconomic status (SES) has been shown to be associated with PA engagement. In a
cross-sectional cohort (n=986) study using data from the Midlife in the United States (MIDUS)
1, MIDUS 2, and MIDAS 2 biomarker trials, SES and PA were examined and compared
with gluco-regulation (76). Socioeconomic status disadvantage scores and PA levels were
obtained using survey responses. Fasting PG and A1C were used to determine glycemic
control. After adjusting for confounders, men and women that had childhood disadvantage and
adult socioeconomic disadvantage were at lower odds of meeting the PA guidelines in LTPA
(OR0.75; 95% CI 0.65–0.86 and OR 0.71; 95% CI 0.62–0.82 , respectively). This study also
found an inverse association between engaging in LTPA and odds of developing either PD or
diabetes.
Environmental barriers to engaging in PA include social support (91), having children,
having a spouse, and space to engage in PA (79). A cross-sectional study of 50,884 women ages
35-74, examined the associations of greenness of residence on PA and obesity (92). Green and
natural land cover was assessed using the U.S. National Land Cover Database. Those in the
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upper tertile of greenness were 17% more likely to expend more than 67.1 metabolic equivalent
(MET) h/wk than those in the lowest tertile (OR 1.17, 95% CI 1.10–1.23). Furthermore, the
prevalence of obesity was lower for those living closer to green spaces.

PHYSICAL ACTIVITY INTERVENTIONS
Several strategies to increase PA for prevention of adverse diabetes outcomes have been
tested. One such strategy involves implementation of the health belief model (HBM), given
successful intervention in breastfeeding (a key factor in losing gestational weight gain) in women
with GDM (93). However, few programs have proved successful due to the challenges that many
of these women face with time, energy, and financial constraints. One diabetes
prevention intervention for women with previous GDM in the past three years involved a webbased walking program that utilized pedometers to measure PA level (94). The intervention was
based around components of the HBM: risk perception, PA and weight self-efficacy, benefits
and barriers to lifestyle change, and "self-regulatory strategies". However, this strategy proved to
have no statistically significant (P>0.05) changes in PA outcomes. McIntyre et al. sought to test
a social cognitive theory-based program in implementing strategies to encourage PA
(95). Results showed some improvement in PA, but minimal. Difficulty in assessing the
effectiveness of the program could be due to the small sample size (n=28). Alternatively, a oneyear pilot study measured the effectiveness of a lifestyle intervention based on selfsufficiency and self-motivation (96). The study was rooted in a behavioral, patient centered
intervention. Although PA did increase by the end of the year, it was not significant (P>0.05)
and several barriers existed in achieving PA goals such as further pregnancies, work and family
obligations, childcare, cultural customs, psychosocial stress, and low SES.
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A successful four-year lifestyle intervention trial addressed nutrition, breastfeeding, and
PA in 586 women (ages 20-49) with prior GDM in Tianjin China (97). Women engaged in at
least 30 minutes of moderate or vigorous exercise every day of the week. The Transtheoretical
Model was used to gradually taper and maintain goals and encourage self-sufficiency. After one
year, mean body weight decreased by 1.4kg. Those who started the trial overweight lost an
average of 2.91 kg. Body mass index, waist circumference, percent body fat, serum insulin level,
and the homeostasis model assessment- insulin resistance decreased significantly more among
women in the intervention group than those in the control group (all P < 0.05).
Social support plays a substantial role in whether enough weekly PA is met (98).
Notably, an intervention using Centering Pregnancy groups focused on group meetings, peer
support, and learned skills needed for treatment (91). This program had better outcomes in
patient PA compliance and neonatal health outcomes than the traditional pregnancy group.
Additionally, fewer women in the program required drug therapy or labor induction and there
was a significant increase in breastfeeding in the program vs traditional.

SUMMARY
Firmly established is the evidence on the glucose regulating benefits of PA in pregnancy.
Physical activity participation has shown to be low in pregnant women and non-pregnant women
with a history of GDM and current diabetes. However, associations of GDM, PD, and T2DM in
pregnancy and PA participation is not fully understood. Furthermore, risk factors associated with
hyperglycemia in pregnancy may also contribute to PA participation. Such factors include racial
minority, having children, and lower SES, among others.
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This review explored the risks and adverse outcomes associated with PD, GDM, and
T2DM in pregnant women, PA recommendations for these groups, improved outcomes and
potential barriers to PA, and interventions. Interventions implemented a wide range of strategies
and exercise modes, addressing various barriers to exercise and PA in women of different
ethnicities. Successful interventions included social and emotional support. Furthermore, there is
a paucity of research on MSA in pregnancy. Most exercise and PA interventions were centered
around AA, with little mention of MSA. Differences in engaging in resistance exercise in pregnant
women with varying glycemic conditions is unclear. It is important to identify differences in AA
and MSA patterns among pregnant women of varying levels of hyperglycemia in conjunction with
potential mediating factors to design effective interventions.
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DATA COLLECTION
This study utilized data from the BRFSS years 2011, 2013, 2015, and 2017. The odd
years between 2011 and 2017 were specifically used because of the inclusion of more detailed
and comprehensive PA questions. The BRFSS is a survey administered via landlines and cell
phones to households in all 50 U.S. states, three U.S. territories, and the District of Columbia (1).
The BRFSS obtains information on participant health behavior, healthcare availability, health
issues, and demographics. Participants must be 18 years or older to complete the survey.
Telephone numbers are randomly sampled in each state or territory by using stratified sampling
techniques. Each state may be considered as one stratum, with division into more strata for
specific sub-regions. Sub-regions may be disproportionately sampled to provide adequate sample
sixes for smaller geographically defined populations. Interviewers are trained specifically for
BRFSS and evaluated each year. Calls were made each month of the year, seven days a week,
and in the daytime and evening (2).

SAMPLE WEIGHTING
Data weighting is used to ensure that the sample is representative of the adult population
in each state. First, the design weight accounts for the probability of selection, nonresponse bias,
and noncoverage areas. The weight of each stratum, the number of phones in a household, and
number of adults in the household are calculated into the design weight. Second, iterative
proportional fitting, or raking, is applied. This weighting adjusts for the demographic differences
between those who are interviewed and the represented population. Raking adjusts for one or a
combination of demographic categories at a time, in an iterative process. The final weight
variable, accounting for design and raking was labeled “_llcpwt”(2). After concatenating survey
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years 2011, 2013, 2015, and 2017, a final weight, labeled “finwt”, was created in SAS version
9.4. This was done to account for the four years of data collection used and was made by
dividing “_llcpwt” by four.

SUBJECTS
The total number of pregnant women between the ages of 18-44 in this BRFSS sample
was 11,079. Age 44 was used as the age cut-off because the pregnancy question was only asked
to women under the age of 45. Women were then excluded if they had incomplete data on
variables of interest or if they were first told by a doctor that they had diabetes at age 5 or
younger (n=1,482). The latter exclusion was to rule out probable type 1 diabetes mellitus
(T1DM). Type 2 diabetes previously accounted for less than 3% of all childhood diabetes cases
(3). However, the incidence of T2DM in children has become more common with rising
childhood obesity (4). A sensitivity analysis was performed to identify what age would be the
best cut-off for the purposes of this study. There was found to be no statistically significant
difference (P>0.05) in outcomes based on excluding at any age point, so the conservative
threshold of age 5 was used, thereby preserving sample power. After removing all observations
with missing information and probable type 1 diabetes, the final sample consisted of 9,597
pregnant women.

CALCULATED VARIABLES
Calculated variables are created by the Centers for Disease Control and Prevention and
readily available for use in the data sets. These variables are derived from variables in the data set
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by combining, reordering, and applying mathematical procedures. Most of these variables are
identified by a leading underscore in the variable name.

PRIMARY DEPENDENT VARIABLES
The primary outcomes of this analysis were calculated from self-reported AA and MSA.
Units of measurement for AA and MSA were minutes per week and days per week, respectively.
AEROBIC ACTIVITY
Minutes of AA were examined continuously and were also dichotomized into “meets the
AA recommendations” and “does not meet the recommendations”. The study sample provided
responses to the following questions regarding AA:
13.1 During the past month, other than your regular job, did you participate in any physical
activities or exercises such as running, calisthenics, golf, gardening, or walking for exercise?
13.2 What type of physical activity or exercise did you spend the most time doing during the past
month? (Participants selected activity/exercise from a list. See Table 1. List of Common Leisure
Activities)
13.3 How many times per week or per month did you take part in this activity during the past
month?
13.4 And when you took part in this activity, for how many minutes or hours did you usually keep
at it?
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13.5 What other type of physical activity gave you the next most exercise during the past month?
(Participants provided type, frequency, and duration of second activity by responding in the same
way as the first activity.)
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Table 1. List of Common Leisure Activities
01 Active Gaming Devices (Wii Fit,
Dance, Dance revolution)
02 Aerobics video or class
03 Backpacking
04 Badminton
05 Basketball
06 Bicycling machine exercise
07 Bicycling 08 Boating (Canoeing,
rowing, kayaking, sailing for pleasure or
camping)
09 Bowling
10 Boxing
11 Calisthenics
12 Canoeing/rowing in competition
13 Carpentry
14 Dancing-ballet, ballroom, Latin, hip
hop, Zumba, etc.
15 Elliptical/EFX machine exercise
16 Fishing from river bank or boat
17 Frisbee
18 Gardening (spading, weeding, digging,
filling)
19 Golf (with motorized cart)
20 Golf (without motorized cart)
21 Handball
22 Hiking – cross-country
23 Hockey
24 Horseback riding
25 Hunting large game – deer, elk
26 Hunting small game – quail
27 Inline Skating
28 Jogging
29 Lacrosse
30 Mountain climbing
31 Mowing lawn
32 Paddleball
33 Painting/papering house
34 Pilates
35 Racquetball
36 Raking lawn/trimming hedges
37 Running
38 Rock climbing 39 Rope skipping

40 Rowing machine exercises
41 Rugby
42 Scuba diving
43 Skateboarding
44 Skating – ice or roller
45 Sledding, tobogganing
46 Snorkeling
47 Snow blowing
48 Snow shoveling by hand
49 Snow skiing
50 Snowshoeing
51 Soccer
52 Softball/Baseball
53 Squash
54 Stair climbing/Stair master
55 Stream fishing in waders
56 Surfing
57 Swimming
58 Swimming in laps
59 Table tennis
60 Tai Chi
61 Tennis
62 Touch football
63 Volleyball
64 Walking
66 Waterskiing
67 Weight lifting
68 Wrestling
69 Yoga
71 Childcare
72 Farm/Ranch Work (caring for
livestock, stacking hay, etc.)
73 Household Activities
(vacuuming, dusting, home repair,
etc.)
74 Karate/Martial Arts
75 Upper Body Cycle (wheelchair
sports, ergometer
76 Yard work (cutting/gathering
wood, trimming, etc.)
98 Other_____

Numbers to the left of each activity are identifying codes for estimating MET values.
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Activities were assigned estimated metabolic equivalent (MET) values and minutes of
moderate or vigorous AA per week were calculated. Finally, the dichotomous variable for
meeting the AA recommendations was created.

MUSCLE STRENGTHENING ACTIVITY
Days per week of MSA were calculated by using the responses to the following question:
13.8 During the past month, how many times per week or per month did you do physical
activities or exercises to STRENGTHEN your muscles? Do NOT count aerobic activities like
walking, running, or bicycling. Count activities using your own body weight like yoga, sit-ups or
push-ups and those using weight machines, free weights, or elastic bands.
The dichotomous variable for meeting the MSA recommendations for adults, of at least two days
per week, was created.

BOTH AEROBIC ACTIVITY AND MUSCLE STRENGTHENING ACTIVITY
The dichotomous variable for meeting the AA recommendation and engaging in at least
two days per week of MSA was created using responses to both AA and MSA questions.

NEITHER AEROBIC ACTIVITY NOR MUSCLE STRENGTHENING ACTIVITY
The dichotomous variable for meeting neither AA or MSA recommendation was created
using responses to both AA and MSA questions.
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PRIMARY INDEPENDENT VARIABLE
The primary independent variable in this study was derived from self-reported diabetes
history. Participants answered the following question: Has a doctor, nurse, or other health
professional EVER told you that you had any of the following? For each, tell me “Yes,” “No,”
or you’re “Not sure.”…
6.12 (Ever told) you have diabetes? (117) If “Yes” and respondent is female, ask: “Was this only
when you were pregnant?”; If respondent says pre-diabetes or borderline diabetes, use response
code 4. The DRS variable was created with three categories: overt diabetes (DM), high-risk for
diabetes (HRD), and no diabetes (ND). Women in the DM group answered “Yes” to question
6.12. Women who answered “Yes, but female told only during pregnancy” or “No, prediabetes
or borderline diabetes” were in the HRD group. Women who answered “No” were in the ND
group.

COVARIATES/DETERMINANTS
The following variables are implemented into the analysis as covariates in linear and
logistic regression models as well as potential determinants of PA engagement.

AGE
Age was divided into five categories: 18-24, 25-29, 30-34, 45-39, and 40-44.
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RACE/ETHNICITY
Race/ethnicity was categorized into eight groups: Caucasian, African American, Asian,
Native American/Alaskan, Pacific Islander/Hawaiian, Hispanic, and Other.

EDUCATION LEVEL
Four levels of education were created: 'less than high school', 'completed high school',
'some college or technical school', and 'graduated college or technical school'.

NUMBER OF CHILDREN IN HOUSELHOLD
Four levels of child household count were created: ‘no children’, ‘one to three children’,
and ‘four or more children’.

ALCOHOL CONSUMPTION
Alcohol consumption was derived from the following questions:
11.1 During the past 30 days, how many days per week or per month did you have at least one
drink of any alcoholic beverage such as beer, wine, a malt beverage or liquor?
11.2 One drink is equivalent to a 12-ounce beer, a 5-ounce glass of wine, or a drink with one
shot of liquor. During the past 30 days, on the days when you drank, about how many drinks did
you drink on the average? NOTE: A 40 ounce beer would count as 3 drinks, or a cocktail drink
with 2 shots would count as 2 drinks.
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11.3 Considering all types of alcoholic beverages, how many times during the past 30 days did
you have X [CATI NOTE: X = 5 FOR MEN, X = 4 FOR WOMEN] or more drinks on an
occasion?
11.4 During the past 30 days, what is the largest number of drinks you had on any occasion?
Alcohol consumption was categorized into three levels: ‘no alcohol’, ‘moderate alcohol
consumption’(no more than 1 drink a day or 7 drinks a week), or ‘heavy alcohol
consumption’(more than 1 drink a day or more than 7 drinks a week).

SMOKING STATUS
Smoking status was divided into three categories: ‘never-smoker’, ‘former smoker’, and
‘current smoker’.

DATA ANALYSIS
Data was managed using SAS version 9.4 (5). Variables of interest were re-coded or
created and missing data points eliminated. Procedures were conducted, accounting for the
complex sample design and weighting. Frequency procedures (PROC SURVEYFREQ) were
used to obtain proportions for sample characteristics. Chi-square (X2) tests for equal proportions
were used to check for statistical significance (P≤0.05). Additional analysis included proportion
estimates of DRS and PA by interview year as well as subgroup analysis of the MSA variable in
women who met the AA recommendation.
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The univariate procedure (PROC UNIVARIATE) was used to check for normality and
provide medians for the continuous AA variable.
Linear regression was performed (PROC SURVEYREG) to obtain beta regression
estimates (β) for AA in HRD and DM groups (ND referent). Three models were created: crude,
age-adjusted, and fully adjusted for all covariates.
Separate logistic regression procedures (PROC SURVEYLOGISTIC) were performed to
obtain odds ratios (ORs) and 95% confidence intervals (CIs) for meeting AA, MSA, both, and
neither 2008 DHHS recommendation according to DRS (ND referent group). Crude, ageadjusted, and fully adjusted models, including all covariates, were constructed for each of the
four outcome variables.
For identification of significant determinants of PA, the covariates in each of the four
fully adjusted logistic models were examined individually by their standardized beta coefficients
(STB), which were obtained by adding the STB modification to the model statements. By taking
the absolute value of the STBs with significant P values ≤ 0.05, covariates could be ranked as
determinants by their contributions to the model.
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ABSTRACT
Objectives

We sought to examine differences in aerobic activity (AA) and muscle
strengthening activity (MSA) by diabetes risk status (DRS) among pregnant
women in the United States.

Background

Pregnant women without complications are advised to engage in PA to mitigate
adverse outcomes. Differences may exist among parous women of diverging
diabetes histories in meeting national PA recommendations.

Methods

The sample (n=9,597) included pregnant women ages 18-44, who participated in
the 2011, 2013, 2015, and 2017 Behavioral Risk Factor Surveillance System.
Levels for DRS were: no diabetes (ND), high risk for diabetes (HRD) due to selfreported gestational diabetes or pre-diabetes, and overt diabetes (DM). Odds
ratios (ORs) for meeting PA recommendations were obtained. Covariates
included age, race, education, household child count, alcohol consumption, and
smoking status.

Results

Findings revealed that on average, group DM had 46.5 fewer minutes of weekly
AA compared to group ND. Furthermore, a significantly lower OR (0.39; P<0.05)
for meeting both recommendations in group DM (referent ND) was observed
after adjustments.

Conclusions

We observed pregnant women with overt diabetes have lower likelihood of
engaging in PA, while group HRD was similar in their PA engagement as group
ND. Differences in demographic variables may contribute to PA outcomes and
strategies in bridging the gap between socioeconomic status and PA engagement
in pregnancy should be explored.
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INTRODUCTION
Hyperglycemia generally refers to the presence of higher than normal glucose levels in
the blood (1). In pregnancy, hyperglycemia may be due to chronic conditions such as type 2
diabetes mellitus (T2DM), prediabetes (PD), and gestational diabetes mellitus (GDM). These
three manifestations of hyperglycemia differ in their diagnostic criteria and severity (1). The
United States (U.S.) prevalence of T2DM and PD in women has increased by at least two
percentage points from 1999-2012, climbing to 13.8% and 35.9%, respectively (2). The
estimated prevalence of GDM in the U.S., based on data from the 2007-2014 National Health
and Nutrition Examination Survey (NHANES) is 7.6% (3).
A T2DM diagnosis can be confirmed by: fasting plasma glucose (PG) ≥126 mg/dl, a
two-hour (2-H) PG ≥200 mg/dl after a 75 g glucose load during oral glucose tolerance test
(OGTT), or a glycohemoglobin (A1C) ≥6.5% (4). Accurate diagnosis requires at least two
separate positive readings for the same test. In addition, one instance of classic symptoms of
hyperglycemic crisis with a random PG ≥200 mg/dl may confirm diagnosis (4). Type 2 diabetes
diagnosis heightens the risk for blindness, kidney failure, lower limb amputations, cardiovascular
events, and complications in pregnancy (5). Type 2 diabetes has also been shown to augment risk
for cardiovascular diseases (CVD) (6).
Prediabetes diagnosis is like that of T2DM, modified with lower cut points: fasting PG
100-125 mg/dL, 2-H OGTT 140-199 mg/dL after a 75g glucose load, and A1C 5.7-6.4% (1). Not
unlike T2DM, PD carries a greater risk of damage to the eyes, kidneys, blood vessels, and heart
(7). Furthermore, 5-10% of patients with PD progress to T2DM annually (8). In order to prevent
disease progression, first line treatment includes: weight loss of 5-10% of body weight and 30
minutes a day of moderate intensity physical activity (PA) (8,9).
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Gestational diabetes initiates in pregnancy and resolves after delivery (2). Diagnosis is
often based on a 3-H 100g OGTT. Diagnosis is confirmed by two or more of: a fasting PG 95125 mg/dl, 1-H PG ≥180 mg/dl, a 2-H PG 155-199 mg/dl, and a 3-H PG 140-199 mg/dl (10).
However, screening methods and diagnostic criteria have varied across years and governing
bodies (11). This has led to varying prevalence estimates and uncertainty for patients who may
not have received GDM diagnosis in previous years (12). Although GDM is not a lifelong
disease, it is associated with over a seven-fold risk for T2DM (13) and a 50% increased risk for
CVD (14). Maternal and fetal sequelae of GDM include increased perinatal mortality, fetal
macrosomia, neonatal hypoglycemia, cesarean section, and postpartum depression (15).
Furthermore, glucose intolerance, T2DM, and obesity risk are heightened in GDM offspring
(16).
Physical activity has been shown to restore insulin sensitivity and minimize impaired
glucose tolerance in pregnancy (17). A meta-analysis of 40 observational studies reported a 30%
reduction in GDM risk for any general inclusion of PA (18). Exercise can positively impact fetal
body composition with an overall increase in fetal weight and decrease in percent of fetal mass.
This is due to improved maternal glucose control, improved maternal autonomic control,
improved placental oxidative stress, and placental efficiency (19).
All U.S. adults without contraindications to exercise, are advised by the Department of
Health and Human Services (DHHS) to stay active (20). The 2008 PA guidelines for adults
recommended either 150 minutes of moderate aerobic activity (AA) or 75 minutes of vigorous
AA and two days of muscle strengthening activities (MSA) per week. Aerobic activity may be
completed in a minimum of 10-minute bouts (21). The new 2018 PA Guidelines for adults are
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comparable to the previous guidelines modified to allow AA bout duration minimums of 2
minutes (20).
Due to their unique medical considerations, pregnant women have separate
recommendations for PA. Current recommendations made by the American College of
Obstetricians and Gynecologists (ACOG) in 2020 state that exercise and/or PA is beneficial for
most pregnant women but modifications in exercises may be necessary to account for
physiological and anatomical changes (22). Pregnant women should be thoroughly evaluated by
an obstetrician-gynecologist before PA recommendations are made to ensure the patient does not
have medical contraindications. Women with uncomplicated pregnancies should be encouraged
to engage in aerobic and muscle strengthening activities (MSA) before, during, and after
pregnancy. Furthermore, activity restriction should not be routinely prescribed as a treatment to
reduce preterm birth (22).
The 2008 and more recent 2018 U.S. DHHS guidelines on PA in pregnancy recommend
at least 150 minutes of moderate-intensity AA per week, avoiding supine position and high fall
risk sports such as horseback riding (20,21). Similarly, the 2019 Canadian guidelines recommend
150 minutes of moderate-intensity aerobic activity (AA) per week, a minimum of three days per
week (23). In addition, Canadian guidelines encourage incorporation of a variety of aerobic and
resistance exercise in addition to yoga, stretching, and pelvic floor muscle training (23).
Although no set dose of MSA has been established for pregnant women, resistance exercise is
encouraged by governing pregnancy experts.
Despite the overwhelming evidence of benefits (24), less than 15% of women achieve the
minimum recommendation of 150 minutes of moderate intensity PA per week during pregnancy
(25). About one third of pregnant women do not engage in any PA (26). Understanding the
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various factors, which may contribute to PA engagement or lack thereof is necessary to create
effective interventions.
Barriers to PA engagement have been studied, including knowledge gaps regarding sports
and exercise and perceived inconvenience (27). Based on a 2017 review of qualitative and
quantitative evidence, among the most prominent barriers to exercise in pregnancy were: lack of
time due to work, tiredness, pregnancy-related symptoms, and lack of social support (28).
Furthermore, there remains prevailing uncertainty among patients and clinical providers
concerning the risk of miscarriage, growth restriction, preterm birth, fatigue, or harm to the fetus
(28).
Though we know that PA recommendations in pregnancy are infrequently met, sparse
information exists on how self-reported GDM and PD histories compare with self-reported
diabetes and euglycemia in meeting AA recommendations and two days of MSA per week. This
study will examine the differences in PA engagement for parous women with varied diabetes risk
status (DRS). Therefore, the study aims to answer three questions: 1) Is there an association
between DRS and meeting the 2008 DHHS PA recommendation in pregnancy? 2) Is there an
association between DRS and engaging in at least two days of MSA per week in pregnancy? 3)
Are there other major determinants that are associated with meeting the recommendations and
two days of MSA in pregnancy?
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METHODS
SAMPLE POPULATION
The data comes from the 2011, 2013, 2015, and 2017 Behavioral Risk Factor
Surveillance System (BRFSS), a population-based survey administered through random-digitdialed landline and cellular telephones. The BRFSS obtains information on participant
demographics, health behaviors, and health related issues. Data is collected on the
noninstitutionalized U.S. civilian population in all 50 states, the District of Columbia, and three
U.S. territories. Sections were stratified according to state regions and within each stratum are
randomized cluster units (households). The raking method for sample weighting was used to
ensure appropriate representation of demographic variables. Participants are pregnant women
between the ages of 18 and 44 who completed all relevant sections of the BRFSS. Women who
reported a diabetes diagnosis at age 5 or younger were excluded, as they were likely to have type
1 diabetes. After excluding incomplete responses and probable type 1 diabetes (n=1,482), there
was a total of 9,597 participants.

EXPOSURE
To obtain the independent variable, DRS, participants were asked if they had ever been
told by a doctor that they had diabetes and whether it was only when they were pregnant.
Women reporting “yes” to this question were given diabetes status. Those who reported diabetes
only in pregnancy or prediabetes were classified as GDM and PDM, respectively, and considered
at a high risk for T2DM. Those who reported having no diabetes were considered to have non-
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diabetes status. Therefore, three DRS groups were established: high risk for diabetes (HRD;
n=457), no diabetes (ND; n=9036), and diabetes (DM; n=104).

OUTCOME
The dependent variables in this study were engaging in AA, MSA, both, and neither
recommendations based on the 2008 DHHS guidelines. To obtain the AA variable, participants
were asked about the type, frequency, and duration of weekly PA performed in the past month.
Depending on the intensity and total minutes of AA, participants either met or did not meet the
AA guidelines. Additionally, minutes of AA were examined as a continuous variable. The
frequency of MSA was obtained by participants being asked the question: “During the past
month, how many times per week or per month did you do physical activities or exercises to
strengthen your muscles?” Depending on the frequency of MSA (less than two times per week or
at least two times per week), participants either met or did not meet the MSA guidelines.

COVARIATES
Covariates included in the analysis were age, race, level of education completed, number
of children in the household, alcohol consumption, and smoking status. Age was divided into
five categories (18-24, 25-29, 30-34, 35-39, and 40-44). Race was categorized into eight groups:
Caucasian, African American, Asian, Native American/Alaskan, Pacific Islander/Hawaiian,
Hispanic, and Other. Education level was categorized into 'less than high school', 'completed
high school', 'some college or technical school', and 'graduated college or technical school'.
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Number of children in the household was sectioned into 'no children', 'one to three children', and
'four or more children'. Alcohol consumption was reported based on the past 30 days prior to
completion of the survey and categorized as 'no alcohol consumption', 'moderate alcohol
consumption' (no more than 1 drink a day or 7 drinks a week), or 'heavy alcohol consumption'
(more than 1 drink a day or 7 drinks a week). Smoking status was categorized as 'non-smoker',
'previous smoker', or 'current smoker'.

STATISTICAL ANALYSIS
Data was analyzed with SAS version 9.4. Variables of interest were re-coded, and
prevalence estimates were stratified by DRS using PROC SURVEYFREQ. All procedures
included the sample weight, strata, and cluster variables to account for the complex stratified
sampling design of BRFSS. PROC SURVEYMEANS was used to determine mean frequencies
for continuous variables. Chi-square (ꭓ2) tests for equal proportions were used to check for
statistical significance (P≤0.05). Normality was checked and medians obtained with PROC
UNIVARIATE.
Beta estimates (β) for the continuous AA variable were obtained using the SURVEYREG
procedure. All variables were then converted to categorical or dichotomous, with aerobic PA,
MSA, both, and neither dichotomized into “meets recommendations” or “does not meet
recommendations”. The SURVEYLOGISTIC procedure allowed for attainment of odds ratios
(ORs) and 95% confidence intervals (CI) related to the proposed research questions.
Furthermore, standardized beta coefficients (STB) were produced. By examining the absolute
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value of the STB and the P-value for statistical significance, covariates from the final model
were ranked as determinants for each outcome.

RESULTS
Table 1 illustrates proportions for sample population characteristics in the total sample
and stratified by DRS. Statistically significant variance in distributions between DRS categories
are observed for age, number of children in the household, and alcohol consumption. Apart from
meeting the MSA recommendation, Table 2 illustrates the general pattern of decreasing
prevalence of PA from ND to HRD to DM.
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Table 1. Characteristics of Pregnant Women by Diabetes Risk Status:
BRFSS 2011, 2013, 2015, 2017
Total
ND
HRD
DM
N (Weighted%)
N=9597
9036 (94.3) 457 (4.8)
104 (0.9)
Total
Age
2113 (28.8) 2033 (29.7) 53 (11.6)
27 (31.7)
18-24
2713 (27.2) 2592 (27.3) 96 (25.5)
25 (23.1)
25-29
2873 (27.9) 2688 (27.5) 162 (37.0)
23 (22.5)
30-34
1485 (12.4) 1351 (12.0) 115 (19.8)
19 (14.1)
35-39
413 (3.7)
372 (3.5)
31 (6.1)
10 (8.6)
40-44
Race/Ethnicity
6203 (51.7) 5882 (52.0) 269 (46.1)
52 (54.8)
White
825 (12.9)
779 (13.1)
34 (8.2)
12 (10.8)
African American
242 (1.3)
224 (1.3)
14 (0.9)
4 (0.6)
Native American/Alaskan
342 (5.9)
317 (5.7)
21 (8.8)
4 (8.6)
Asian
78 (0.2)
7 (0.8)
3 (0.5)
Native Hawaiian/ Pacific Islander 88 (0.3)
1584 (26.0) 1463 (25.6) 96 (33.0)
25 (21.2)
Hispanic
313 (1.9)
293 (1.9)
16 (2.1)
4 (3.4)
Other
Education Level
Did not complete HS
Completed HS
Some college/technical school
Graduated college/technical
school
Number of Children in
Household
None
1-3 children
4 or more
Alcohol Consumption (Based
on the past 30 days)
None
Moderate
Heavy
Smoking Status
Never smoker
Former smoker
Current smoker

777 (16.2)
2176 (24.2)
2553(28.9)
4091 (30.7)

710 (15.8)
2030 (24.1)
2403 (29.2)
3893 (30.9)

56 (22.9)
113 (26.1)
122 (24.8)
166 (26.1)

11 (15.4)
33 (27.9)
28 (22.7)
32 (34.0)

χ2 Test
P
<.0001

0.1571

0.1948

0.0024
2981 (33.1)
5979 (60.2)
637 (6.6)

2862 (33.8)
5594 (59.7)
580 (6.5)

87 (19.8)
324 (72.0)
46 (8.2)

32 (38.5)
61 (51.4)
11 (10.1)
<.0001

8606 (88.8)
883 (9.2)
108 (1.1)

8091 (88.6)
848 (10.0)
97 (1.4)

429 (93.5)
23 (5.2)
5 (1.3)

86 (78.4)
12 (14.8)
6 (6.8)

6758 (70.3)
2012 (21.0)
827 (8.7)

6398 (71.7)
1864 (19.6)
774 (7.3)

292 (64.9)
126 (27.7)
39 (7.4)

68 (68.0)
22 (20.1)
14 (11.9)

0.1091

BRFSS: Behavioral Risk Factor Surveillance System; ND: no diabetes; HRD: high-risk for diabetes due to selfreported gestational diabetes or prediabetes; DM: overt diabetes; HS: high school; level of significance set to P≤0.05
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Table 2. Prevalence Estimates for Physical Activity According to Diabetes Risk Status:
BRFSS 2011, 2013, 2015, 2017
Diabetes
Status

No AA

No MSA

Meets AA
Recᵃ

Meets
MSA
Recᵇ

Meets Both
Recsc

Meets
Neitherd

n (weighted %)
ND
N=9036

2525
(27.9%)

6265
(69.3%)

3709
(39.2%)

1681
(16.9%)

1087
(10.9%)

4733
(54.8%)

HRD
N=457

150
(32.8%)

358
(78.3%)

182
(39.2%)

60
(15.7%)

42
(10.5%)

257
(55.6%)

DM
N=104

65 (62.5%)

80 (76.9%)

36
(30.1%)

13
(17.9%)

7
(5.0%)

62
(57.0%)

Total
N=9597

2720
(28.3%)

6674
(69.5%)

3927
(39.2%)

1754
(16.8%)

1135
(10.8%)

5052
(54.8%)

BRFSS: Behavioral Risk Factor Surveillance System; ND: no diabetes; HRD: high-risk for diabetes due to selfreported gestational diabetes or prediabetes; DM: overt diabetes; AA: aerobic activity; MSA: muscle strengthening
activity; ᵃ2008 Department of Health and Human Services (DHHS) recommendation of 150 minutes of moderate
intensity AA/wk.ᵇ2008 DHHS recommendation of 2 days/wk of MSA. cboth “a” and “b”; dneither “a” nor “b”;
level of significance set to P≤0.05; Variance in distributions were statistically significant (P<0.05) for all measures.

DIFFERENCES IN AEROBIC ACTIVITY BY DIABETES RISK STATUS
Table 3 provides β values for minutes of AA per week in the HRD and DM groups (ND
referent) for crude, age adjusted, and fully adjusted models. There was a non-normal distribution
for the continuous AA variable, but the sample size was large enough to allow for linear
regression without violations. On average, those with diabetes had 46.5 fewer minutes in AA
compared to those with no diabetes. Having GDM or PD contributes modestly to the likelihood
of engaging in AA when compared to having no diabetes.
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Table 3. Linear Regression for Aerobic Activity in per Week in Pregnancy by Diabetes Risk
Status
HRD

DM

Model

β (SE)

β (SE)

Crude

-23.6 (0.041)

-45.9 (0.041)

Age Adjusted

-22.2 (0.036)

-43.4 (0.320)

Fully Adjusteda

-2.51 (0.078)

-46.5 (0.078)

Accounts for age, race/ethnicity, education level, number of children in the household, alcohol consumption, and smoking;
β: beta regression estimate; HRD: high risk for diabetes due to self-reported gestational diabetes or prediabetes; DM: overt
diabetes; SE:standard error P<0.0001 level of significance for all values listed
a

ODDS RATIOS FOR PHYSICAL ACTIVITY
Table 4 represents odds of meeting AA, MSA, both, and neither 2008 DHHS
recommendations. After adjustments, the odds of meeting both AA and MSA recommendations
were approximately 60% lower in the DM group (ND referent; OR 0.39; CI 0.19-0.82). No other
statistically significant relationship between DRS and PA recommendations was observed.

MUSCLE STRENGTHENING ACTIVITY DIFFERENCES
Interestingly, although the odds of meeting both recommendations were significantly
lower in group DM (Table 4), the prevalence of MSA was slightly higher (Table 2). Not
illustrated are the median number of days of MSA per week in women reporting at least one day
of MSA in the past 30 days: 2.00, 2.00, and 1.00 in groups ND, HRD, and DM, respectively.
Table 5 exhibits results from a subgroup analysis limited to only women who met the AA
recommendations to determine whether the DM subgroup differ in meeting the MSA
recommendations when compared to the ND and HRD subgroups. Although not statistically
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significant (P=0.3382), the percentage of meeting the MSA recommendations (16.5% SE 6.0%)
was lower than ND and HRD percentages (27.8% and 26.9%, respectively).

Table 4. Odds Ratios for Meeting Physical Activity Recommendations by Diabetes Risk
Status

Crude

Ageadjusted

Fully
adjusteda

Meets AA

Meets MSA

Meets Both

Meets Neither

HRD

OR=0.96
CI=0.66-1.40

OR=1.00
CI=-0.58-1.72

OR=0.96
CI=0.44-2.08

OR=1.03
CI=0.72-1.49

DM

OR=1.02
CI=0.53-1.95

OR=0.36
CI=0.11-1.12

OR=0.43*
CI=0.2-0.91

OR=1.09
CI=0.64-1.86

HRD

OR=1.01
CI=0.70-1.48

OR=1.09
CI=0.60-1.98

OR=0.96
CI=0.44-2.10

OR=1.02
CI=0.71-1.47

DM

OR=0.67
CI=0.39-1.17

OR=0.93
CI=0.44-1.99

OR=0.43*
CI=0.20-0.92

OR=1.08
CI=0.64-1.8

HRD

OR=1.07
CI=0.72-1.59

OR=1.15
CI=0.66-2.00

OR=1.23
CI=0.58-2.60

OR=0.93
CI=0.64-1.36

DM

OR=0.64
CI=0.37-1.11

OR=1.00
CI=0.45-2.23

OR=0.39*
CI=0.19-0.82

OR=1.15
CI=0.68-1.95

*P<0.05 level of significance; aAdjusted for age, race/ethnicity, education level, number of children in

household, alcohol consumption, and smoking status; AA: aerobic activity; MSA: muscle strengthening activity;
ᵃ2008 Department of Health and Human Services (DHHS) recommendation of 150 minutes of moderate intensity
AA/wk.ᵇ2008 DHHS recommendation of 2 days/wk of MSA. cboth “a” and “b”; dneither “a” nor “b”; HRD: high
risk for diabetes due to self-reported gestational diabetes or prediabetes; DM: overt diabetes Referent group: no
diabetes
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Table 5. Proportions of Pregnant Women Meeting the MSAᵃ Recommendations Among
those who Meet the AAᵇ Recommendation
ND
HRD
DM
n
1087
42
7
Percent
27.8
26.9
16.5
Standard Error
1.2
7.9
6.0
P Value* = 0.3382
*P value derived from Wald Chi-Square Test; ᵃ2008 Department of Health and Human Services (DHHS)
recommendation of 2 days/wk of muscle strengthening activity; ᵇ2008 DHHS recommendation of 150 minutes of
moderate intensity aerobic activity/wk; ND: no diabetes; HRD: high risk for diabetes due to self-reported
gestational diabetes or prediabetes; DM: overt diabetes

DETERMINANTS OF PHYSICAL ACTIVITY
Table 6 describes the top three determinants associated with the odds of meeting the 2008
DHHS recommendations. The odds of meeting the AA recommendation were predominantly
negatively influenced by self-reported African American, Hispanic, or Asian race. The odds of
meeting the MSA recommendation were positively impacted by consuming alcohol in the past
30 days and completing more than high school and negatively impacted by having 1-3 children
at home. The odds of meeting both and neither recommendations were highly influenced by a
combination of the top three AA and MSA determinants.
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Table 6. Top Three Determinants of Meeting AA and MSA Recommendations
PA Recommendation

Determinant

STB

P value

AAᵃ
1
2
3
MSAᵇ

African American
Hispanic
Asian

-1.28
-1.16
-1.08

<0.0001
0.0015
0.0043

2.00

<0.0001

1.90
-1.62

0.0002
<0.0001

-1.97

<0.0001

1.75

<0.0001

-1.58

0.016

-1.40

<0.0001

1.37
1.26

0.0001
<0.0001

1
2
3
Both c
1
2
3
Neither d
1
2
3

Consumed Alcohol in Past 30
Days
Completed > HS
1-3 Children at Home
1-3 Children at Home
Consumed Alcohol in Past 30
Days
African American
Consumed Alcohol in Past 30
Days
Hispanic
African American

HS: High School; PA: physical activity; AA: aerobic activity; MSA: muscle strengthening activity; ᵃ2008
Department of Health and Human Services (DHHS) recommendation of 150 minutes of moderate intensity
AA/wk.ᵇ2008 DHHS recommendation of 2 days/wk of MSA. c both “a” and “b”; d neither “a” nor “b”; STB:
Standardized beta coefficient; All variables included in the model were diabetes risk status, age, race, education
level, number of children in household, alcohol consumption, and smoking status

TRENDS OF PHYSICAL ACTIVITY AND DIABETES RISK STATUS: 2011-2017
From Table 7, we can see no statistically significant change in meeting 2008 DHHS PA
recommendations (P>0.05) across BRFSS interview years. However, the slight and consistent
uptrend in MSA, from 15% in 2011 to 19% in 2017, should be noted. Furthermore, no
significance was seen in distribution of DRS in pregnancy by interview year (Figure 1), although
a five-fold increase in overt diabetes prevalence from 2011 to 2017 may be observed.

85

Table 7. Prevalence of Meeting PA Recommendations in Pregnancy by Year

Year

2011

2013

2015

2017

n

(n=2773)

(n=2638)

(n=2031)

(n=2155)

Recommendation

n (%)

n (%)

n (%)

n (%)

PValue

AAᵃ

1122 (39.9)

1056 (38.1)

855 (37.8)

894 (40.7)

0.5954

MSA ᵇ

438 (15.0)

469 (15.5)

403 (17.8)

444 (19.0)

0.1061

Both c

284 (10.1)

295(9.8)

267 (11.6)

290 (11.7)

0.5129

χ2 Test

Percentages are weighted; ; ᵃ2008 Department of Health and Human Services (DHHS) recommendation of 150
minutes of moderate intensity AA/wk.ᵇ2008 DHHS recommendation of 2 days/wk of MSA. cboth “a” and “b”
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Figure 1. Trends in Prevalence of Overt Diabetes and High-Risk for Overt Diabetes in
Pregnancy: BRFSS 2011-2017

Percentages are weighted.

DISCUSSION
This study combines GDM and PD together as one high-risk for diabetes group. Though
secondary to diabetes, both GDM and PD carry gravid and post-gravid health threats (7,13-16).
Given the relatively small numbers of self-reported pregnancy in our study population, and even
lower prevalence of hyperglycemic pregnancies, we combined four recent survey years of
BRFSS data in an attempt to acquire enough power to examine our associations of interest.
Lack of statistical significance in odds of meeting individual AA and MSA
recommendations may be due to the overall diminished PA engagement in pregnancy (29),
attenuating differences among DRS groups. Furthermore, relatively small sample sizes for DM
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and HRD groups may have contributed to a loss of statistical power to accurately demonstrate
some relationships. With regards to meeting the AA guidelines, our study found no significant
differences in ORs after adjusting for covariates in the fourth model. This mirrors previous
findings from a 2003 BRFSS study examining nonpregnant women ages 18-44 (n=4718), with
and without a history of GDM where there was no difference in meeting the AA guidelines
between groups after adjusting for age, race, education level, current employment, marital status,
presence of children in household, smoking status, self-rated health, and BMI .
Markedly observed in this study is the inverse association of overt diabetes and meeting
both AA and MSA recommendations. This finding is reflective of a BRFSS study on
nonpregnant women, reporting that non-pregnant women of a childbearing age with current
diabetes are 40% more likely to fail to meet LTPA their recommendations compared with their
non-diabetes counterparts (P<0.05).
Top determinants for odds of meeting the U.S. DHHS PA guidelines for adults closely
mirrored differences in sample population characteristics. African American, Hispanic, and
Asian race/ethnicities negatively influenced the odds of meeting AA recommendations.
Although there was no significance in the distribution (P=0.1571), there may be intra-variability
in these race/ethnicity categories. Specifically, 33% of the HRD group was Hispanic compared
to 26% of the ND group and 21% of the DM group. Published evidence has identified Hispanic
minority as major demographic risk factor for GDM, a large portion of the HRD group (16).
Furthermore, being part an ethnic minority is associated with higher diabetes prevalence (30).
We found that completing more than high school positively impacted the odds of meeting
the MSA recommendations while lower education level has been identified as a predictor for
T2DM (30). Having 1-3 children significantly contributed to higher odds of MSA. Having four
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or more children was not a top determinant, most likely due to insufficient cell size. Future
studies may consider using a broader “one or more children” category. Such dichotomization
was used in a 2001-2003 BRFSS study that observed a higher prevalence of having at least one
child in women with GDM (~87% vs ~66% in no GDM group; p<0.01). Furthermore, having
GDM and at least one child living at home were associated with compromised healthy lifestyle
behaviors (9).
Given the widespread discouragement of alcohol consumption in pregnancy and
deleterious effects of alcohol on fetal development (31), the strong positive influence of alcohol
consumption on odds of meeting MSA and both recommendations in pregnancy seem peculiar.
However, alcohol consumption has been observed to favorably improve the odds of meeting
MSA guidelines in adults with dyslipidemia and augmented waist circumference (32). In another
study examining the relationship between alcohol consumption and metabolic syndrome in
adults, moderate and above moderate alcohol consumption was positively associated with
improved metabolic factors, including decreased PG levels (33). More research is needed to
understand this relationship outside of pregnancy. However, existing evidence on the harmful
effects of alcohol exposure on the fetus still warrant caution during pregnancy (31)
This study was not without its limitations. The cross-sectional nature of BRFSS does not
allow us to infer causality. According to a 2015 CDC report, 31.1% of all U.S. women have
PDM but only 14.1% are aware of their disease state (34). Since our study relied on self-report,
we may have mistakenly classified a large percentage of high-risk women as normal, which may
have buffered the true influence of diabetes status on PA participation. Variables that may
provide additional information when accounting for risk that were not included in the survey
include pre-pregnancy BMI, specific diabetes subtypes, pre-conception care, and
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contraindications to exercise. In particular, the lack of information on gestational age hindered us
from identifying women that may be overweight or obese and whether they were far enough
along to be eligible for GDM screening/diagnosis. Furthermore, the study sample size did not
allow examination of determinants of PA by DRS, due to unstable cell sizes.
Although MSA recommendations are not specified in the 2018 DHHS guidelines for
pregnant women, we opted to include the MSA guidelines of two days of MSA per week in the
general adult population. Strength training needs greater emphasis due to its role in diabetes
prevention. In a prospective cohort study (35), resistance exercise and lower intensity MSA were
both associated with a lower risk of T2DM in the pooled analysis. Greater glycemic load
increased with greater volume of MSA, suggesting improved insulin sensitivity with this mode
of activity (35). Resistance training has also been shown to improve feelings of fatigue
associated with pregnancy (36,37).
Preconception counseling, with PA included, is recommended by the ADA (38).Clinical
recommendations for promoting exercise in pregnant women with PD, GDM, and T2DM have
been established (22,39). However, many women with diabetes are not meeting with clinical
providers to receive prenatal counseling (40). Moreover, cognitive dissonance may exist
regarding healthy lifestyle and other lifestyle factors. Several strategies to increase PA
participation in pregnancy have been proposed. In a systematic review examining behavior
change interventions, goals and planning with feedback was found to be the most effective
behavior change technique (41). Other interventions based on social support and self-efficacy
have also proven effective (42,43). Interventions specifically targeting aspects of SES
disadvantage may prove efficacious, as women at socioeconomic disadvantage are less likely to
meet LTPA guidelines (44).
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Furthermore, women in general may not be receiving quality counseling by their
physicians on exercise in pregnancy (45, 46) It is essential that pregnant women are advised to
exercise by their physicians as they will be more likely to engage in PA (47). Increased
education by healthcare providers may also ameliorate feelings of uncertainty among certain
women. Feeling unsafe/unsure about moderate PA may be associated with non-White
race/ethnicity, low education, low income, and not participating in moderate PA with no
intention to start exercising (48).

CONCLUSION
Pregnancy is an opportunity for clinicians to encourage healthy lifestyle patterns,
including PA. This study illuminates the health disparities associated with DRS and PA
participation in pregnancy. Future studies should examine PA prevalence using objective
measures of PA participation, hyperglycemia, and clinical assessment of participants. Ultimately,
increased efforts should be made for interventions targeted at improving health outcomes by
breaching the gaps in regular AA and MSA participation during pregnancy for women with DM,
and characteristics such as multiple children, lower education, and/or racial/ethnic minority
backgrounds, improving health outcomes.
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